Mead Johnson (MJN) Tops Q3 EPS by 1c; Boosts FY11 EPS Outlook, Still Below Views
Tweet
Share
E-mailGet Alerts MJN Hot Sheet
Join SI Premium – FREE
Mead Johnson Nutrition Co. (NYSE: MJN) reported Q3 EPS of $0.78, $0.01 better than the analyst estimate of $0.77. Revenue for the quarter came in at $933.9 million versus the consensus estimate of $934.14 million.
Mead Johnson Nutrition Co. sees FY2011 EPS of $2.73-$2.78, versus prior guidance of $2.70-$2.75 and the consensus of $2.79.
Mead Johnson Nutrition Co. sees FY2011 EPS of $2.73-$2.78, versus prior guidance of $2.70-$2.75 and the consensus of $2.79.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent, Inc. (COHR) Tops Q4 EPS by 12c, Offers Guidance
- ATARA Biotherapeutics (ATRA) Misses Q2 EPS by 10c
- Kura Oncology (KURA) Tops Q2 EPS by 11c, Beats on Revenue
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
